By David | Biotech News Today
The San Francisco Bay Area is often called Biotech Bay, and for good reason. It is home to a very large share of the world’s biotech activity, from early-stage startups to global drug makers. This guide explains why so many biotech startups settle in the Bay Area, where the main clusters are, which companies are worth knowing, and what the current funding pressure means for newcomers.
If you are new to the topic, start with our guide on what biotech startups are and how they get funded.
Why the Bay Area Became a Biotech Hub
The region’s rise started in South San Francisco, where Genentech was founded in the 1970s and helped create the modern biotech industry. Since then, success has fed more success: scientists leave established companies to found new ones, investors follow the talent, and suppliers and service firms move in nearby.
Several advantages keep the cluster strong:
- Research institutions: Top universities and medical centers produce a steady flow of discoveries and graduates.
- Venture capital: Many life science investors are based in or near the region.
- Talent pool: Experienced scientists, clinical specialists, and manufacturing experts live and work close together.
- Technology crossover: Proximity to Silicon Valley helps companies apply software and artificial intelligence to drug discovery.
- Lab space: Developers have built large amounts of purpose-made laboratory space, especially in South San Francisco.
The Main Biotech Clusters Around the Bay
Biotech Bay is not one place. Different areas have different strengths.
| Area | What It Is Known For |
|---|---|
| South San Francisco | The historic center of the industry, with a dense group of drug developers and large lab campuses |
| Mission Bay, San Francisco | Companies and research linked to the University of California, San Francisco |
| Peninsula (Redwood City, San Carlos, Menlo Park) | Mix of therapeutics, tools, and platform companies |
| East Bay (Emeryville, Berkeley, Alameda) | Early-stage startups, gene editing, and synthetic biology |
| Brisbane and Burlingame | Spillover growth near South San Francisco |
| South Bay (San Jose and nearby) | Diagnostics, devices, and tech-linked life science |
According to the City of South San Francisco, its biotech cluster includes over 250 companies and about 12 million square feet of biotech space, and most of those companies work on biopharmaceutical research and development. The city expects the amount of life science space to roughly double between 2019 and 2035.
Companies and Startups Worth Knowing
The Bay Area mixes large, established companies with a long list of younger firms. Genentech, now part of the Roche Group, is based in South San Francisco and works across areas such as cancer, eye disease, neuroscience, and immune conditions. Denali Therapeutics, also in South San Francisco, focuses on neuroscience and rare disease. IDEAYA Biosciences, in the same city, works on precision cancer medicines. Lyell Immunopharma is another South San Francisco company, working on cell therapies, while Mammoth Biosciences in Brisbane works on gene editing technology.
These are examples, not a ranking. Company sizes, pipelines, and ownership change often, so always check a company’s own website for its latest status.
| Company | Location | Main Focus |
|---|---|---|
| Genentech | South San Francisco | Cancer, eye disease, neuroscience, immunology |
| Denali Therapeutics | South San Francisco | Neuroscience and rare disease |
| IDEAYA Biosciences | South San Francisco | Precision oncology |
| Lyell Immunopharma | South San Francisco | Cell therapy |
| Mammoth Biosciences | Brisbane | Gene editing |
Many of the newest startups are spin-outs from these companies or from local universities, which is one reason the cluster keeps renewing itself.
Funding Pressure: What Startups Face Right Now
The Bay Area is not immune to the tough funding climate in biotech. A February 2026 industry article reported that, according to an Ernst & Young survey, nearly 40 percent of Bay Area biotech companies had less than a year of cash. It also noted layoffs at several companies in the region. Funding conditions change quickly, so treat any single survey as a snapshot rather than a forecast.
For founders, this usually means:
- Reaching clear scientific milestones before raising the next round
- Seeking partnerships with larger drug makers
- Controlling costs and focusing on a smaller number of programs
- Considering outsourcing to avoid building expensive facilities. See what a CDMO is.
Why Startups Still Choose the Bay Area
Even with high costs and tighter funding, many founders stay because the ecosystem solves problems that are hard to fix elsewhere. A new company can hire experienced staff, meet investors in person, and find lab space and service providers within a short drive. Large companies also operate nearby, which makes partnerships and acquisitions more likely. To understand how those larger companies differ from startups, read biotech vs pharma.
Tips for Students and Job Seekers
- Look for internships and entry-level roles in South San Francisco, Mission Bay, and the East Bay.
- Check each company’s cash position and clinical progress before applying.
- Build both lab skills and data skills, since many companies now blend biology with computing.
- Follow local industry news and events to meet people in the field.
- Learn the basics first with our Biotechnology 101 guide.
Frequently Asked Questions
Why is the Bay Area called Biotech Bay? Because it has one of the largest concentrations of biotech companies, researchers, and investors in the world, beginning with the industry’s early growth in South San Francisco.
Where are most Bay Area biotech startups located? South San Francisco is the biggest cluster, followed by Mission Bay in San Francisco, the Peninsula, and the East Bay.
Is it hard to raise money as a Bay Area biotech startup? Funding has been tight recently, and investors want strong scientific data. Companies with clear milestones and partnerships have an easier time.
Do Bay Area biotech startups only make drugs? No. The region also has companies in diagnostics, gene editing, devices, agriculture, and industrial biotechnology.
Is the Bay Area a good place for a biotech career? It offers many opportunities and strong networks, though living costs are high and startup jobs can be less secure than jobs at large companies.
Final Thoughts
The Bay Area remains one of the strongest places in the world to build a biotech company, thanks to its talent, investors, and research base. At the same time, startups there face the same funding pressure as the rest of the industry. Keep following Biotech News Today for practical guides and updates on the companies shaping the field.
Sources
- City of South San Francisco, Biotech in SSF: https://www.ssfca.gov/Our-City/Biotech/Biotech-in-SSF
- Cure, 11 Biggest Biotech Companies in the Bay Area (February 2026): https://wewillcure.com/insights/company-profiles/biggest-biotech-companies-in-bay-area
- BioSpace, Biotech Bay: https://www.biospace.com/biotech-bay
Leave a Reply